UBE2V1P6

Across TCGA pan-cancer cohorts, UBE2V1P6 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated UBE2V1P6 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher UBE2V1P6 RNA is associated with better overall survival. In most high-consensus cancer types, elevated UBE2V1P6 expression acts as an unfavorable survival marker, although some lineages such as SKCM and ESCA show a favorable association.

SKCM, MESO, and THYM are the cancer types where UBE2V1P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	1.000	0.861	.001	111	view →
MESO	OS	Tertile	III,IV	0.052	0.567	<.001	72	view →
THYM	OS	Tertile	All	0.039	0.928	<.001	72	view →
STAD	DFS	Tertile	II,III,IV	0.541	0.739	.014	44	view →
LUAD	DFS	Tertile	All	0.303	0.661	.028	27	view →
ESCA	OS	Quartile	III,IV	0.651	0.317	.008	21	view →
PRAD	OS	Tertile	All	0.869	0.990	<.001	18	view →
PAAD	OS	Tertile	II,III,IV	0.366	0.569	.032	9	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	9	view →
GBM	DFS	Tertile	All	0.120	0.256	.008	9	view →
LIHC	OS	Tertile	III,IV	0.268	0.652	.035	9	view →
LAML	DFS	Quartile	All	0.274	0.494	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

UBE2V1P6–SKCM (OS)

Open the SKCM breakdown →